According to Royalty Pharma's latest financial reports the company's current earnings (TTM) are $1.88 B. In 2022 the company made an earning of $0.41 B a decrease over its 2021 earnings that were of $1.40 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $1.88 B | 351.47% |
2022 | $0.41 B | -70.3% |
2021 | $1.40 B | -24.3% |
2020 | $1.85 B | -31.9% |
2019 | $2.72 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | $6.66 B | 253.10% | ๐บ๐ธ USA |
Eli Lilly LLY | $6.55 B | 247.30% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | $19.87 M | -98.95% | ๐บ๐ธ USA |